Health Risk Analysis:
Technical Adequacy in Three Selected Cases
PEMD-87-14: Published: Sep 30, 1987. Publicly Released: Sep 30, 1987.
Additional Materials:
- Full Report:
Contact:
GAO evaluated the risk analysis processes used by the Food and Drug Administration (FDA), the Occupational Safety and Health Administration (OSHA), and the Environmental Protection Agency (EPA) to identify possible weaknesses and strengths in the processes.
GAO found that: (1) risk assessment work generally met acceptable technical and scientific criteria; (2) FDA and OSHA did a credible job of reviewing and evaluating available evidence on a hazard; and (3) problems in risk assessment were primarily related to data availability. GAO also found that: (1) there were significant problems in risk management work; (2) FDA and EPA poorly documented the development and evaluation of risk management options and decisionmaking processes; (3) the extent and quality of risk management guidelines varied greatly between and within the agencies; and (4) none of the agencies conducted follow-up evaluations of the regulations to determine if they were achieving the intended risk reduction effects.
Feb 24, 2021
Covid-19:
Key Insights from GAO's Oversight of the Federal Public Health ResponseGAO-21-396T: Published: Feb 24, 2021. Publicly Released: Feb 24, 2021.
Feb 17, 2021
Feb 11, 2021
-
Operation Warp Speed:
Accelerated COVID-19 Vaccine Development Status and Efforts to Address Manufacturing ChallengesGAO-21-319: Published: Feb 11, 2021. Publicly Released: Feb 11, 2021.
Feb 5, 2021
-
DOD Health Care:
DOD Should Monitor Implementation of Its Clinical Practice GuidelinesGAO-21-237: Published: Feb 5, 2021. Publicly Released: Feb 5, 2021. -
Medicaid:
CMS Needs to Implement Risk-Based Oversight of Puerto Rico's Procurement ProcessGAO-21-229: Published: Feb 5, 2021. Publicly Released: Feb 5, 2021. -
VA Health Care:
Community Living Centers Were Commonly Cited for Infection Control Deficiencies Prior to the COVID-19 PandemicGAO-21-195R: Published: Jan 6, 2021. Publicly Released: Feb 5, 2021.
Jan 28, 2021
-
COVID-19:
Critical Vaccine Distribution, Supply Chain, Program Integrity, and Other Challenges Require Focused Federal AttentionGAO-21-265: Published: Jan 28, 2021. Publicly Released: Jan 28, 2021.
Jan 21, 2021
-
Rural Hospital Closures:
Affected Residents Had Reduced Access to Health Care ServicesGAO-21-93: Published: Dec 22, 2020. Publicly Released: Jan 21, 2021. -
Health Care Funding:
Federal Obligations to and Funds Received by Certain Organizations Involved in Health-Related Services, 2016 through 2018GAO-21-188R: Published: Dec 21, 2020. Publicly Released: Jan 21, 2021.
Jan 14, 2021
-
Medicaid:
Data Completeness and Accuracy Have Improved, Though Not All Standards Have Been MetGAO-21-196: Published: Jan 14, 2021. Publicly Released: Jan 14, 2021.
Looking for more? Browse all our products here
Explore our Key Issues on Health Care
- Air Quality
- Border Security and Immigration
- Children's Health and Safety
- Drug Misuse
- Elder Abuse
- Health Care Quality
- Health Information Technology
- Improper Payments
- Improving Federal Programs that Serve Tribes and Their Members - High Risk Issue
- Managing Risks and Improving VA Health Care
- Medicaid - High Risk Issue
- Medical Product Oversight - High Risk Issue
- Medicare - High Risk Issue
- Prescription Drug Spending
- Supports and Services for Transitioning Veterans
- Toxic Chemicals - High Risk Issue
- Tribal and Native American Issues
- VA and DOD Health Care Management
- VA and DOD Patient Care
- Women and Gender in Public Policy
Explore our other Key Issues here
